Status:
COMPLETED
Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia
Lead Sponsor:
Imperial College London
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
In this study the investigators will obtain histological samples from people with hereditary haemorrhagic telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome).
Detailed Description
HHT is an inherited condition that leads to the development of dilated and fragile blood vessels. We propose to obtain small skin samples from patients with HHT in order to analyze the samples using h...
Eligibility Criteria
Inclusion
- Patients with Hereditary Haemorrhagic Telangiectasia
Exclusion
- Unable to provide informed consent
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00733655
Start Date
September 1 2008
End Date
August 1 2016
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN